Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic

Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowled...

Descripción completa

Detalles Bibliográficos
Autores principales: Luykx, Jurjen J., van Veen, Sisco M. P., Risselada, Arne, Naarding, Paul, Tijdink, Joeri K., Vinkers, Christiaan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248582/
https://www.ncbi.nlm.nih.gov/pubmed/32362299
http://dx.doi.org/10.1192/bjp.2020.92
Descripción
Sumario:Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

Ejemplares similares